fda warning letters glp-1 september 2025 news Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded medications. Read more at the link in the comments below FDA Drug Recalls and Warnings:

doi: 10.3389/fnut.2025.1541054 Received 06 December 2024 Accepted 20 March 2025 Published 09 April 2025 Volume 12 - 2025 Edited by Peng An, China Agricultural University, China Reviewed by Naseem Akhtar Qureshi, Al-Falah University, India Denis Fedorinov, Russian Medical Academy of Postgraduate Education, Russia Updates Copyright 2025 Overton, Emelyanova and Bunik

KLOW's mechanism overlaps with metformin (AMPK activation) and GLP-1 agonists (improved beta-cell function)

Matrix metalloproteinases in emphysema

Many physicians believe that GLP-1R agonists are underutilized and should be expanded to populations without diabetes or obesity

Tablet count alone does not show whether two products are clinically comparable

Trauma Theory Res